Literature DB >> 9740279

Cryptosporidium infection in HIV-seropositive and seronegative populations in southern Thailand.

S Uga1, N Kunaruk, S K Rai, M Watanabe.   

Abstract

The prevalence of Cryptosporidium infection in 61 HIV-seropositive and 61 HIV-seronegative subjects (aged less than one to 67-year-old) in Songkhla City, southern Thailand was studied by a centrifugal flotation technic using sucrose solution. Most of the HIV-seropositive subjects (72%) were 20 to 39 years old. Cryptosporidium oocysts were detected in 10% (6/61) of HIV-seropositive and in 2% (1/61) of HIV-seronegative subjects. Infection rates in these two groups, however, were not statistically significant (p > 0.05). The number of Cryptosporidium oocysts observed in 20 microscopic fields ranged between one and over 12,000. Among the seven Cryptosporidium-positive subjects, six were adults (18 to 42-year-old) and one was three-year-old child. All of the Cryptosporidium infected subjects were male, and two of them were passing formed (normal) feces. Biochemical findings revealed dishepatica in five of six Cryptosporidium infected HIV-seropositive subjects.

Entities:  

Mesh:

Year:  1998        PMID: 9740279

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  3 in total

1.  Prevalence and genotyping of Cryptosporidium isolated from HIV/AIDS patients in urban areas of Thailand.

Authors:  M Srisuphanunt; W Saksirisampant; P Karanis
Journal:  Ann Trop Med Parasitol       Date:  2011-09

Review 2.  Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients.

Authors:  Paul R Hunter; Gordon Nichols
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

3.  Prevalence and molecular characterization of human and bovine Cryptosporidium isolates in Thailand.

Authors:  Chadaporn Nuchjangreed; Kajohn Boonrod; Jerry Ongerth; Panagiotis Karanis
Journal:  Parasitol Res       Date:  2008-08-16       Impact factor: 2.289

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.